Skip to content

Treatment of Abdominal Abscesses With or Without Fibrinolysis

Treatment of Abdominal Abscesses With or Without Fibrinolysis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01597336
Enrollment
92
Registered
2012-05-14
Start date
2009-06-30
Completion date
2014-05-31
Last updated
2015-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Abscess, Tissue Plasminogen Activator

Keywords

abscess, tPA

Brief summary

The objective of this study is to evaluate the utility of fibrinolysis when draining an abdominal abscess as defined by length of stay after drainage.

Detailed description

The hypothesis is that fibrinolysis of a abscess will shorten hospital stay compared to drainage alone.

Interventions

PROCEDURETissue plasminogen activator abscess flush

Thirteen ml of 10% tPA in saline at time of drain and twice daily thereafter.

PROCEDURESaline flush of abscess

Thirteen ml of saline is used to flush abscess at time of drain placement and twice daily thereafter.

Sponsors

Children's Mercy Hospital Kansas City
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 17 Years
Healthy volunteers
No

Inclusion criteria

* Patients under age 18 found to have an abscess in their abdomen related to perforated appendicitis that requires a drain either prior to or after appendectomy.

Exclusion criteria

* Patients with known immune deficiency per medical record review * Patients with another condition affecting surgical decision making or recovery * Patients with drain unable to be placed

Design outcomes

Primary

MeasureTime frameDescription
Length of hospital stay1-2 weeksLength of time required for meeting discharge criteria

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026